Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

KGC

Kinross Gold Corp

Feb 13 • 04:00PM ET

34.40

+2.04 6.30 %

Basic Materials • Gold • Canada • NYSE

Peers: NEM B AEM AU BVN GFI IAG HMY AGI SAND

| Held by: GDX DIHP DFIC DFAX DFAI MGNR IGE GBUG LST DFIV

Index	-	P/E	24.00	EPS (ttm)	1.43	Insider Own	0.59%	Shs Outstand	1.21B	Perf Week	7.20%
Market Cap	41.52B	Forward P/E	11.48	EPS next Y	3.00	Insider Trans	0.00%	Shs Float	1.20B	Perf Month	3.33%
Enterprise Value	41.17B	PEG	0.17	EPS next Q	0.56	Inst Own	59.78%	Short Float	1.79%	Perf Quarter	32.16%
Income	1.76B	P/S	6.44	EPS this Y	155.57%	Inst Trans	1.46%	Short Ratio	2.16	Perf Half Y	82.11%
Sales	6.44B	P/B	5.23	EPS next Y	72.37%	ROA	15.37%	Short Interest	21.52M	Perf YTD	22.16%
Book/sh	6.58	P/C	23.92	EPS next 5Y	68.87%	ROE	24.09%	52W High	39.11 -12.04%	Perf Year	201.49%
Cash/sh	1.44	P/FCF	18.98	EPS past 3/5Y	63.79% 6.28%	ROIC	19.09%	52W Low	10.32 233.33%	Perf 3Y	722.97%
Dividend Est.	0.12 (0.36%)	EV/EBITDA	10.97	Sales past 3/5Y	25.58% 8.04%	Gross Margin	43.01%	Volatility	4.85% 5.22%	Perf 5Y	366.12%
Dividend TTM	0.12 (0.36%)	EV/Sales	6.39	EPS Y/Y TTM	139.19%	Oper. Margin	40.07%	ATR (14)	1.87	Perf 10Y	1046.67%
Dividend Ex-Date	Nov 26, 2025	Quick Ratio	1.68	Sales Y/Y TTM	32.90%	Profit Margin	27.30%	RSI (14)	54.11	Recom	1.74
Dividend Gr. 3/5Y	0.00% -	Current Ratio	2.83	EPS Q/Q	66.57%	SMA20	-0.63%	Beta	0.74	Target Price	41.82
Payout	15.79%	Debt/Eq	0.16	Sales Q/Q	25.84%	SMA50	9.71%	Rel Volume	1.12	Prev Close	32.36
Employees	-	LT Debt/Eq	0.16	Earnings	Feb 18 AMC	SMA200	52.03%	Avg Volume	9.95M	Price	34.40
IPO	Nov 01, 1982	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.59% 4.57%	Trades		Volume	11,158,930	Change	6.30%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-28-25	Initiated	Desjardins	Buy
Aug-04-25	Initiated	UBS	Buy	$20
Jun-30-25	Resumed	Raymond James	Mkt Perform	$15
Jun-26-25	Upgrade	Jefferies	Hold → Buy	$18
Apr-16-25	Resumed	BMO Capital Markets	Outperform
Feb-29-24	Resumed	Jefferies	Hold	$5.50 → $5
Sep-12-23	Initiated	Desjardins	Buy
Apr-05-23	Downgrade	BofA Securities	Buy → Underperform	$4.70
Jan-30-23	Downgrade	Barclays	Overweight → Equal Weight
Apr-20-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$6
Mar-03-22	Downgrade	Credit Suisse	Outperform → Neutral	$7 → $5.25
Jul-30-21	Upgrade	National Bank Financial	Sector Perform → Outperform
Jun-23-21	Upgrade	Credit Suisse	Neutral → Outperform	$7.50 → $8
Jun-22-21	Downgrade	National Bank Financial	Outperform → Sector Perform
Jun-22-21	Downgrade	CIBC	Sector Outperform → Neutral	$11.25 → $8.50
Feb-10-21	Resumed	JP Morgan	Overweight
Jan-06-21	Upgrade	Barclays	Equal Weight → Overweight	$9
Aug-05-20	Upgrade	BofA Securities	Neutral → Buy	$11.25
Jun-16-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$7 → $7.50
Apr-16-20	Upgrade	Scotiabank	Sector Perform → Sector Outperform

Show Previous Ratings

Feb-16-26 12:46PM	New Gold to Report Q4 Results: What's in the Cards for the Stock? (Zacks)
11:08AM	Royal Gold Gets Ready to Report Q4 Earnings: Here's What to Expect (Zacks)
11:07AM	B2Gold Gears Up to Report Q4 Earnings: Here's What to Expect (Zacks)
10:49AM	AGI Gears Up to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
07:55AM	Here's How to Play Kinross Gold Stock Before Q4 Earnings Release (Zacks)
12:00AM	Loading…
12:00AM	Upcoming Meeting Dates - February 16, 2026 (Newsfile)
Feb-13-26 10:40AM	Gold Leader Flashes Strength Headed Into Earnings (Investor's Business Daily) +6.30%
08:55AM	These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:32AM	Newmont Surges 73% in 6 Months: Buy, Sell or Hold the Stock? (Zacks)
05:19AM	Wall Street Bullish on ?Kinross Gold Corporation (KGC) Ahead of its Fiscal Q4 2025 Earnings (Insider Monkey)
Feb-12-26 12:10PM	Why Kinross Gold (KGC) is Poised to Beat Earnings Estimates Again (Zacks) -7.06%
10:00AM	Newmont Corporation (NEM) Earnings Expected to Grow: Should You Buy? (Zacks)
09:15AM	Kinross Gold (KGC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Feb-11-26 04:04PM	The Week Ahead: Holiday-Shortened Week Brings Fed Minutes (Schaeffer's Research)
10:00AM	Kinross Gold (KGC) Earnings Expected to Grow: Should You Buy? (Zacks)
08:13AM	Loading…
08:13AM	Agnico Eagle Stock Rallies 26% in 3 Months: What Should Investors Do? (Zacks)
Feb-10-26 09:50AM	Kinross Gold (KGC) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
08:53AM	Should You Buy Agnico Eagle Mines Stock Ahead of Q4 Earnings? (Zacks)
Feb-09-26 10:28AM	Smurfit Westrock to Report Q4 Earnings: What's in Store for the Stock? (Zacks) +5.73%
10:11AM	International Flavors to Report Q4 Earnings: What's in Store? (Zacks)
Feb-06-26 12:41PM	Gold Stocks Eye An Encore After Historic Rally (Investor's Business Daily)
10:35AM	CIBC Raises Kinross Gold (KGC) PT to $54 with Outperformer Rating (Insider Monkey)
07:04AM	Which Mining Firms Are Striking It Rich in the Metals Rally? (MarketBeat)
Feb-05-26 10:44AM	Linde Q4 Earnings Beat on Higher Americas Pricing, Revenues Rise Y/Y (Zacks) -5.25%
08:21AM	Albemarle to Post Q4 Earnings: What's in the Offing for the Stock? (Zacks)
Feb-04-26 10:37AM	The Zacks Analyst Blog Highlights Agnico Eagle Mines, Kinross Gold and Newmont (Zacks)
09:45AM	Here's Why Kinross Gold (KGC) is a Strong Growth Stock (Zacks)
07:36AM	Barrick Mining Pops 51% in 3 Months: Here's How to Play the Stock (Zacks)
Feb-03-26 11:55AM	Bunge Ready to Report Q4 Earnings: What's in Store for the Stock? (Zacks) +5.45%
09:28AM	3 Gold Mining Stocks Set to Pull Off a Beat This Earnings Season (Zacks)
09:40AM	Loading…
Feb-02-26 09:40AM	Here's Why Kinross Gold (KGC) is a Strong Value Stock (Zacks)
09:15AM	Linde Set to Report Q4 Earnings: What's in Store for the Stock? (Zacks)
08:08AM	Should You Buy, Sell or Hold Barrick Mining Ahead of Q4 Earnings? (Zacks)
Jan-30-26 08:40AM	Intuitive Surgical and KB Home have been highlighted as Zacks Bull and Bear of the Day (Zacks) -13.77%
Jan-29-26 01:21PM	Will AngloGold Ashanti's Expansion Strategy Fuel Long-Term Growth? (Zacks)
Jan-28-26 09:08AM	Can Kinross Gold's Profits Keep Shining Amid Higher Costs? (Zacks)
09:07AM	LyondellBasell to Post Q4 Earnings: What's in the Cards for the Stock? (Zacks)
08:55AM	Why Investors Need to Take Advantage of These 2 Basic Materials Stocks Now (Zacks)
Jan-27-26 12:10PM	International Paper Set to Report Q4 Earnings: What's in Store? (Zacks)
07:03AM	DOW Gears Up for Q4 Earnings: What's in the Cards for the Stock? (Zacks)
Jan-23-26 01:59PM	Gold Stocks Soar To Highs As Precious Metal Nears $5,000 Mark (Investor's Business Daily)
Jan-22-26 05:00PM	Kinross to announce 2025 Q4/full-year results and 2026 guidance on February 18, 2026 (GlobeNewswire)
09:16AM	Agnico Eagle vs. Kinross Gold: Which Gold Miner Is Shining Brighter? (Zacks)
08:30AM	If You Invested $1000 in Kinross Gold a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
Jan-21-26 09:24AM	Nucor to Report Q4 Earnings: What's in the Offing for the Stock? (Zacks)
09:15AM	Agnico Eagle Mines Limited (AEM) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jan-19-26 12:19PM	KGC Progresses With Three Organic Growth Projects in the US (Zacks)
Jan-16-26 11:56AM	First Majestic's Q4 Silver-Equivalent Production Jumps 37% Y/Y (Zacks)
09:06AM	CC to Sell Former Titanium Dioxide Taiwan Site Land for $360M (Zacks)
09:06AM	Can Centerra Gold Hold On To Its Strong Production Momentum? (Zacks)
09:00AM	How to Find Strong Buy Basic Materials Stocks Using the Zacks Rank (Zacks)
Jan-15-26 09:53AM	Zacks Investment Ideas feature highlights: Kinross Gold, Agnico Eagle Mines and Royal Gold (Zacks)
09:45AM	Why Kinross Gold (KGC) is a Top Growth Stock for the Long-Term (Zacks)
08:47AM	Ingevity Rises More Than 18% in 3 Months: What's Driving the Stock? (Zacks)
08:41AM	BASFY to Strengthen Solutions With AgBiTech Acquisition (Zacks)
08:19AM	Nutrien Gains on Healthy Fertilizer Demand, Acquisitions & Cost Cuts (Zacks)
08:12AM	5 Growth Stocks to Buy in January for a Stronger Portfolio (Zacks)
07:56AM	Does Kinross Gold's 212% Surge in a Year Justify Buying It Now? (Zacks)
06:45AM	Kinross proceeds with construction of Phase X, Curlew and Redbird 2 (GlobeNewswire)
02:50AM	Is Newmont Stock Still a Buy After a 26% Rally in 3 Months? (Revised) (Zacks)
Jan-14-26 12:22PM	Why Gold Mining Stocks May Still Have Room to Run (Zacks)
10:23AM	ARKAY's New Rilsan Polyamide Unit Begins Operations in Singapore (Zacks)
10:21AM	BASFY's Polyamide Materials Meet New eMobility Requirements (Zacks)
Jan-13-26 11:11AM	SSR Mining Advances With Hod Maden Project: Will it Aid Growth? (Zacks)
09:55AM	IPI & Partners Progress to Jointly Develop Lithium Project in Utah (Zacks)
08:55AM	How to Boost Your Portfolio with Top Basic Materials Stocks Set to Beat Earnings (Zacks)
08:36AM	Is Newmont Stock Still a Buy After a 26% Rally in 3 Months? (Zacks)
08:34AM	Can Kinross Gold Sustain Its Robust Margin Momentum in Q4? (Zacks)
08:27AM	Analyst Report: Kinross Gold Corporation (Morningstar Research)
Jan-12-26 12:10PM	Why Kinross Gold (KGC) Could Beat Earnings Estimates Again (Zacks) +5.44%
10:50AM	Algoma Steel Sees Q4 Loss on Tariffs and Blast Furnace Wind-Down (Zacks)
08:55AM	How to Boost Your Portfolio with Top Basic Materials Stocks Set to Beat Earnings (Zacks)
08:22AM	Buy These 5 Dividend Growth Stocks Amid Conflicting Labor Market Data (Zacks)
08:21AM	Is AEM Stock a Screaming Buy After the 132% Price Surge in a Year? (Zacks)
08:19AM	4 Gold Stocks to Watch as Record Prices Extend Into 2026 (Zacks)
07:34AM	Albemarle Shares Surge 76% in a Year: What's Driving the Rally? (Zacks)
Jan-09-26 10:37AM	Can Agnico Eagle's Ultra-Low Debt Profile Fuel Bigger Growth? (Zacks)
09:57AM	Olin Revises Q4 2025 EBITDA Outlook Citing Segment Shortfall (Zacks)
Jan-08-26 11:42AM	CBT Signs Agreement to Supply EV Battery Materials to PowerCo (Zacks)
07:00AM	Kinross to provide update on Round Mountain Phase X, Kettle River-Curlew and Bald Mountain Redbird 2 projects (GlobeNewswire)
Jan-07-26 10:48AM	IAMGOLD Soars 144% in 6 Months: Here's How to Play the Stock (Zacks)
09:33AM	ArcelorMittal Secures Long-Term Low-Carbon Power Supply From EDF (Zacks)
05:48AM	Zacks.com featured highlights include Kinross Gold and Willdan (Zacks)
Jan-06-26 03:00PM	These 2 Stocks Are Up 100%+ in 2025-and the Momentum Isn't Over (Zacks)
11:40AM	KGC vs. FNV: Which Stock Is the Better Value Option? (Zacks)
10:35AM	Ingevity Completes Divestiture of CTO Refinery Assets to Mainstream (Zacks)
10:32AM	Element Solutions Acquires EFC, Adds to its High-Value Portfolio (Zacks)
08:49AM	Is Barrick Mining Stock Worth Buying After a 195% Surge in a Year? (Zacks)
08:30AM	Here's How Much a $1000 Investment in Kinross Gold Made 10 Years Ago Would Be Worth Today (Zacks)
Jan-05-26 09:16AM	PKX Advances LFP Cathode Materials Business With New JV (Zacks)
Jan-02-26 10:44AM	Here's Why You Should Retain Carpenter Technology Stock for Now (Zacks)
10:13AM	What's Behind Ingevity's 27% Rally in the Past 6 Months? (Zacks)
Dec-31-25 10:39AM	IFF Gains From Focus on Growth Despite Low Food Ingredient Volumes (Zacks)
09:36AM	Stepan Continues Footprint Optimization Through LA Asset Sale (Zacks)
09:00AM	Looking for Basic Materials Stocks? The Zacks Rank Can Help You Find Winners (Zacks)
08:32AM	Olin Suffers From High Debt Burdens and Dampened Demand (Zacks)
06:25AM	The Zacks Analyst Blog Highlights First Majestic Silver, Agnico Eagle Mines, Kinross Gold and Fortuna Mining (Zacks)
Dec-30-25 11:28AM	TSX higher as mining shares rebound on gold and silver recovery (Investing.com)
11:26AM	Kinross Gold Stock Rallies 81% in 6 Months: What's Behind the Upside? (Zacks)
10:52AM	AG Stock Soars 205% in a Year: What's Aiding Its Performance? (Zacks)

Kinross Gold Corp. engages in the production, acquisition, exploration, and development of gold properties. The firm operates through the following business segments: Tasiast, Paracatu, La Coipa, Fort Knox, Round Mountain, Bald Mountain, and Corporate & Other. The Fort Knox segment includes Fort Knox and Manh Choh mine. Its mining operations are in the United States, Brazil, Chile, Mauritania, and Canada. The company was founded by Robert MacKay Buchan on May 31, 1993 and is headquartered in Toronto, Canada.

TEVA Teva- Pharmaceutical Industries Ltd. ADR daily Stock Chart

Peers: VTRS PRGO AMRX GSK BMY PFE MRK NVS ABBV JNJ

| Held by: IEFA EFA EIS EFV IXUS SPDW IDEV FNDF PPH WCMI

Index	-	P/E	27.91	EPS (ttm)	1.22	Insider Own	0.16%	Shs Outstand	1.15B	Perf Week	-2.05%
Market Cap	38.97B	Forward P/E	11.02	EPS next Y	3.08	Insider Trans	-28.78%	Shs Float	1.15B	Perf Month	4.11%
Enterprise Value	52.61B	PEG	2.00	EPS next Q	0.55	Inst Own	63.80%	Short Float	3.31%	Perf Quarter	31.55%
Income	1.42B	P/S	2.24	EPS this Y	-7.72%	Inst Trans	-2.41%	Short Ratio	3.76	Perf Half Y	93.73%
Sales	17.39B	P/B	4.94	EPS next Y	14.02%	ROA	3.54%	Short Interest	37.95M	Perf YTD	8.88%
Book/sh	6.88	P/C	10.96	EPS next 5Y	5.52%	ROE	21.37%	52W High	37.35 -9.01%	Perf Year	104.33%
Cash/sh	3.10	P/FCF	38.82	EPS past 3/5Y	- -	ROIC	6.12%	52W Low	12.47 172.60%	Perf 3Y	229.90%
Dividend Est.	-	EV/EBITDA	10.51	Sales past 3/5Y	5.53% 0.80%	Gross Margin	51.82%	Volatility	1.74% 3.04%	Perf 5Y	205.58%
Dividend TTM	-	EV/Sales	3.03	EPS Y/Y TTM	185.43%	Oper. Margin	22.96%	ATR (14)	0.93	Perf 10Y	-39.05%
Dividend Ex-Date	Nov 27, 2017	Quick Ratio	0.80	Sales Y/Y TTM	4.72%	Profit Margin	8.16%	RSI (14)	57.82	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	1.04	EPS Q/Q	313.26%	SMA20	1.39%	Beta	0.72	Target Price	39.11
Payout	0.00%	Debt/Eq	2.17	Sales Q/Q	12.42%	SMA50	6.56%	Rel Volume	0.49	Prev Close	33.92
Employees	33346	LT Debt/Eq	1.93	Earnings	Jan 28 BMO	SMA200	54.12%	Avg Volume	10.09M	Price	33.98
IPO	Feb 16, 1982	Option/Short	Yes / Yes	EPS/Sales Surpr.	49.70% 9.13%	Trades		Volume	5,010,709	Change	0.18%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Overweight	$35
Dec-05-25	Initiated	Scotiabank	Sector Outperform	$35
Jun-06-25	Initiated	Goldman	Buy	$24
May-28-25	Initiated	Truist	Buy	$25
May-12-25	Upgrade	JP Morgan	Neutral → Overweight	$23
Jul-10-24	Upgrade	Argus	Hold → Buy	$20
Mar-08-24	Upgrade	JP Morgan	Underweight → Neutral	$14
Feb-12-24	Upgrade	Piper Sandler	Neutral → Overweight	$12 → $19
Jan-23-24	Upgrade	Jefferies	Hold → Buy	$10 → $14
Jan-03-24	Upgrade	Piper Sandler	Underweight → Neutral	$8 → $12
Dec-18-23	Initiated	HSBC Securities	Buy	$13
Nov-27-23	Upgrade	UBS	Neutral → Buy	$11 → $13
Jul-06-23	Upgrade	UBS	Sell → Neutral	$7 → $8
May-25-23	Initiated	Morgan Stanley	Equal-Weight	$10
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $12
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy	$10
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy	$10 → $13

Show Previous Ratings

Today 07:04AM	Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients (Benzinga)
06:00AM	Teva and Sanofi's duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn's disease (GlobeNewswire)
Feb-10-26 06:41AM	Here's What Analysts Are Saying About Teva Pharmaceutical (TEVA) Post Earnings (Insider Monkey)
Feb-04-26 09:05AM	Barclays Raises Teva Pharmaceutical (TEVA) PT to $38 Following Strong Q4 Earnings Beat (Insider Monkey)
Feb-03-26 09:34PM	Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory (Insider Monkey)
01:30AM	Loading…
Feb-02-26 01:30AM	The Druckenmiller Connection: Meet the Man Behind Bessent and Warsh (Barrons.com)
Jan-31-26 09:35AM	Analysts See Pipeline Catalysts Driving Teva Pharmaceutical Industries Limited (TEVA)'s 2026 Growth Despite Revenue Headwinds (Insider Monkey)
08:48AM	Jim Cramer Highlights Teva Pharmaceutical's Growth Under CEO Richard Francis (Insider Monkey)
Jan-30-26 10:08AM	Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic (Benzinga)
Jan-29-26 12:36PM	Novo Nordisk Faces Class Action Over Victoza Generic Delay (GuruFocus.com)
11:23AM	TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth (Zacks)
10:05AM	What Makes Teva Pharmaceuticals (TEVA) a Successful Brand? (Insider Monkey)
12:06AM	Teva Pharmaceutical Industries Q4 Earnings Call Highlights (MarketBeat)
Jan-28-26 04:26PM	Teva CEO Explains 'Remarkable Story' Behind Guidance (Investor's Business Daily)
03:25PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
01:01PM	Loading…
01:01PM	Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday? (Benzinga)
12:22PM	Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook (Benzinga)
11:10AM	Should You Stay Invested in J&J Stock After Q4 Beat & Solid Guidance? (Zacks)
10:02AM	Teva Pharma Slides On 2026 Guidance Surprise Despite Fourth-Quarter Beat (Investor's Business Daily)
09:40AM	Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock (Zacks)
09:30AM	Teva Pharmaceutical Industries (TEVA) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:46AM	Teva Pharma Slides On Light 2026 Outlook Despite Fourth-Quarter Beat (Investor's Business Daily)
07:00AM	Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential (GlobeNewswire)
Jan-27-26 10:51AM	J&J Targets $100B+ Sales in 2026 as Growth Accelerates in Both Units (Zacks)
08:00AM	Will Forte Teams Up with Teva to Get Real About Huntington's Disease with 'Honestly HD' (GlobeNewswire)
Jan-23-26 09:15AM	What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q4 Earnings (Zacks)
Jan-21-26 12:14PM	Dr. Reddy's Laboratories Q3 Earnings Call Highlights (MarketBeat)
10:28AM	J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales (Zacks)
Jan-19-26 09:07AM	Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results? (Zacks)
Jan-16-26 08:53AM	JPM26: AbbVie highlights growth drivers as it moves away from Humira dependency (Pharmaceutical Technology)
08:52AM	Loading…
08:52AM	ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now? (Zacks)
Jan-15-26 09:50AM	Teva Pharmaceutical Industries Ltd. (TEVA) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Jan-14-26 05:02PM	AJOVY (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine (GlobeNewswire)
Jan-13-26 09:04PM	Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 (MarketBeat)
04:48PM	Teva's Plans to Pivot to Growth (Bloomberg)
11:16AM	Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial (Benzinga)
Jan-12-26 12:26PM	Teva Taps Royalty Pharma For $500M To Advance Skin Disease Drug (Benzinga)
10:46AM	Teva Stock Is Jumping. Why Investors Are So Optimistic on the Drugmaker. (Barrons.com)
10:08AM	TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug (Zacks)
09:40AM	Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term (Zacks)
Jan-11-26 06:00PM	Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation (GlobeNewswire)
05:00PM	Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo (GlobeNewswire)
Jan-10-26 02:57PM	Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32 (Insider Monkey)
Jan-06-26 11:44AM	ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now? (Zacks)
11:15AM	Will Galafold Be Able to Aid FOLD's Top Line Heading Into Q4 Earnings? (Zacks)
Jan-05-26 04:30PM	Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
09:07AM	Should You Buy the Dip in This S&P 500 Underdog in 2026? (Barchart)
Dec-30-25 07:40AM	Here's What to Expect From Deckers Outdoor's Next Earnings Report (Barchart)
Dec-29-25 11:59PM	What Do Analysts Think About Teva Pharmaceutical Industries (TEVA)? (Insider Monkey)
Dec-26-25 10:45AM	This International Pharma Stock Just Hit 5-Year Highs (Barchart)
Dec-24-25 08:36AM	S&P Global Ratings Upgrades Teva to 'BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive (GlobeNewswire)
04:11AM	Billionaire Stanley Druckenmiller Sold Nvidia and Palantir and Piled Into One of Wall Street's Hottest Drug Stocks Ahead of 2026 (Motley Fool)
Dec-22-25 11:21AM	J&J Stock Trading Above 50- & 200-Day SMA for 6 Months: How to Play (Zacks)
Dec-19-25 03:40AM	Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea (GlobeNewswire)
03:26AM	My Top 10 Portfolio Holdings for 2026 (Motley Fool)
Dec-18-25 09:40AM	Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock (Zacks)
Dec-17-25 05:09PM	BofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight (Insider Monkey)
02:53PM	3 Things You Need to Know if You Buy Teva Pharmaceutical Stock Today (Motley Fool)
07:44AM	S&P 500 Stocks: These 2 Lagging Retailers Become Leaders In December (Investor's Business Daily)
Dec-16-25 10:30AM	FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock? (Zacks)
Dec-14-25 03:47PM	Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? (Motley Fool)
Dec-12-25 04:30PM	Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026 (GlobeNewswire)
04:30PM	Teva Releases Q4 2025 Aide Memoire (GlobeNewswire)
Dec-11-25 08:26PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
10:11AM	Crypto Market 2026 Predictions: Which Coins Will 10x and Which Will Crash? (24/7 Wall St.)
10:11AM	Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks (24/7 Wall St.)
Dec-10-25 09:24PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
09:43AM	TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia (Zacks)
Dec-09-25 11:12AM	Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play (Zacks)
08:00AM	Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults (GlobeNewswire)
04:53AM	Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Dr. Reddy's (Zacks)
Dec-08-25 11:10AM	Can J&J Offset Stelara LOE, MedTech China and Legal Headwinds in 2026? (Zacks)
08:23AM	3 Generic Drug Stocks to Watch Amid Changing U.S. Landscape (Zacks)
03:34AM	Is Deckers Outdoor Stock Underperforming the S&P 500? (Barchart)
Dec-06-25 09:52AM	Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue (24/7 Wall St.)
Dec-05-25 09:57AM	Can Galafold Continue to Drive Amicus' Top Line in 2026? (Zacks)
Dec-04-25 12:18PM	Israel Has Been Mired In Controversy During Its War With Hamas. Big Tech Investment Tells A Different Story. (Investor's Business Daily)
Dec-02-25 09:40AM	Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term (Zacks)
Nov-30-25 03:14AM	30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks (Motley Fool)
Nov-26-25 04:11PM	Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied (Investor's Business Daily) +5.32%
Nov-25-25 08:41AM	What Are Wall Street Analysts' Target Price for Deckers Outdoor Stock? (Barchart)
08:10AM	Teva receives European Commission approvals for PONLIMSI (denosumab) Biosimilar to Prolia and DEGEVMA (denosumab) Biosimilar to Xgeva (GlobeNewswire)
Nov-24-25 12:38PM	This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks Hes Buying Now. (24/7 Wall St.)
Nov-21-25 04:30PM	Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December (GlobeNewswire)
Nov-19-25 08:00AM	Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma's Biggest Challenges (GlobeNewswire)
Nov-18-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-14-25 08:44AM	ANI Pharmaceuticals Stock Surges 53% YTD: Time to Buy or Sell? (Zacks)
Nov-13-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-11-25 03:51AM	Billionaire Stanley Druckenmiller Sold His Fund's Entire Stakes in Nvidia and Palantir for a Scorching-Hot Drug Stock That's Up 218% Since Mid-2023 (Motley Fool)
Nov-10-25 09:40AM	Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? (Zacks)
Nov-07-25 06:00PM	AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living (GlobeNewswire)
09:40AM	Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? (Zacks)
Nov-06-25 11:18AM	TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock Up (Zacks)
05:43AM	Teva (TEVA) Hits All-Time High as Q3 Strengthens FY25 Profitability Expectations (Insider Monkey)
Nov-05-25 05:53PM	Why Teva Pharmaceutical Stock Rocked the Market Today (Motley Fool) +20.23%
04:31PM	Teva Rockets, Reaffirming Its $2.5 Billion View For Austedo After IRA Negotiations (Investor's Business Daily)
04:21PM	Apple's reported Google deal, Teva & Axon post-earnings moves (Yahoo Finance Video)
02:00PM	Teva Pharmaceutical Industries Ltd (TEVA) Q3 2025 Earnings Call Highlights: Strong Growth ... (GuruFocus.com)
12:58PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
11:05AM	Teva Rockets Into A Profit-Taking Zone On Austedo's Big Sales Beat (Investor's Business Daily)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weiss Amir	Chief Accounting Officer	Dec 16 '25	Sale	30.20	12,300	371,504	5,650	Dec 18 04:04 PM
MIGNONE ROBERTO	Director	Dec 16 '25	Sale	30.24	77,400	2,340,646	367,600	Dec 18 04:02 PM
Bridger Management, LLC (1)	Shareholder	Dec 12 '25	Proposed Sale	30.18	150,000	4,527,000		Dec 12 04:17 PM
Daniell Richard	Exec. VP, European Commercial	Dec 09 '25	Option Exercise	18.40	115,468	2,124,542	163,852	Dec 11 04:09 PM
Daniell Richard	Exec. VP, European Commercial	Dec 09 '25	Sale	28.68	115,468	3,311,126	48,384	Dec 11 04:09 PM
Sabag Mark	See "Remarks"	Dec 09 '25	Option Exercise	18.61	118,724	2,209,454	269,720	Dec 11 04:06 PM
Sabag Mark	See "Remarks"	Dec 09 '25	Sale	28.73	216,892	6,230,754	52,828	Dec 11 04:06 PM
Sabag Mark	Officer	Dec 09 '25	Proposed Sale	28.73	216,892	6,230,750		Dec 09 04:03 PM
Daniell Richard	Officer	Dec 09 '25	Proposed Sale	28.68	115,468	3,311,131		Dec 09 04:00 PM
MIGNONE ROBERTO	Director	Nov 26 '25	Sale	26.03	50,000	1,301,505	445,000	Dec 01 04:02 PM
Bridger Management, LLC (1)	Shareholder	Nov 26 '25	Proposed Sale	24.99	50,000	1,249,500		Nov 26 04:02 PM
Fox Christine	EVP, Head of U.S. Commercial	Nov 20 '25	Sale	24.78	28,229	699,523	63,647	Nov 24 04:03 PM
Fox Christine	Officer	Nov 20 '25	Proposed Sale	24.78	28,229	699,523		Nov 20 04:19 PM
Fox Christine	EVP, Head of U.S. Commercial	Nov 14 '25	Sale	25.11	30,000	753,321	28,384	Nov 18 04:01 PM
Fox Christine	Officer	Nov 14 '25	Proposed Sale	25.11	30,000	753,321		Nov 14 03:59 PM
MIGNONE ROBERTO	Director	Nov 06 '25	Sale	24.11	200,000	4,821,880	495,000	Nov 10 04:15 PM
Weiss Amir	Chief Accounting Officer	Nov 06 '25	Sale	24.44	12,300	300,564	17,950	Nov 10 04:06 PM
Bridger Management, LLC (1)	Shareholder	Sep 12 '25	Proposed Sale	19.89	95,000	1,889,550		Sep 12 04:05 PM
McAvoy David R.	EVP, Chief Legal Officer	Sep 05 '25	Buy	18.86	1,113	20,988	13,027	Sep 09 04:02 PM
Jover Placid	See "Remarks"	Aug 01 '25	Sale	15.16	6,053	91,748	6,774	Aug 05 04:04 PM
Hughes Eric A	See "Remarks"	Aug 01 '25	Sale	15.16	52,742	799,437	0	Aug 05 04:02 PM
Jover Placid	Officer	Aug 01 '25	Proposed Sale	15.16	6,053	91,748		Aug 01 04:04 PM
Hughes Eric A	Officer	Aug 01 '25	Proposed Sale	15.16	52,742	799,437		Aug 01 04:01 PM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Jun 12 '25	Sale	17.08	55,775	952,464	403,288	Jun 16 04:03 PM
Kalif Eliyahu Sharon	Officer	Jun 12 '25	Proposed Sale	17.08	55,775	952,466		Jun 12 04:18 PM
Shields Matthew	EVP, Global Operations	Jun 03 '25	Sale	17.02	6,206	105,628	9,989	Jun 05 05:08 PM
Shields Matthew	Officer	Jun 03 '25	Proposed Sale	17.02	6,206	105,628		Jun 03 03:59 PM
Sabag Mark	See "Remarks"	May 08 '25	Sale	18.04	337,915	6,097,304	150,996	May 12 04:00 PM
Sabag Mark	Officer	May 08 '25	Proposed Sale	18.04	337,915	6,097,324		May 08 02:34 PM
Daniell Richard	Exec. VP, European Commercial	Mar 05 '25	Sale	15.91	70,961	1,128,642	48,384	Mar 07 04:05 PM
Hughes Eric A	See "Remarks"	Mar 04 '25	Sale	15.73	15,174	238,757	8,077	Mar 06 04:11 PM
Hughes Eric A	See "Remarks"	Mar 05 '25	Sale	15.91	8,077	128,531	0	Mar 06 04:11 PM
Daniell Richard	Exec. VP, European Commercial	Mar 04 '25	Sale	15.73	91,608	1,441,415	7,108	Mar 06 04:06 PM
Daniell Richard	Exec. VP, European Commercial	Mar 05 '25	Sale	15.91	48,764	775,991	0	Mar 06 04:06 PM
Francis Richard D	President and CEO	Mar 04 '25	Sale	15.73	15,514	244,107	280,042	Mar 06 04:03 PM
Francis Richard D	President and CEO	Mar 05 '25	Sale	15.91	8,259	131,427	271,783	Mar 06 04:03 PM
Daniell Richard	Officer	Mar 05 '25	Proposed Sale	15.83	70,961	1,123,585		Mar 05 04:29 PM
Daniell Richard	Exec. VP, European Commercial	Mar 03 '25	Sale	16.19	49,314	798,172	12,936	Mar 05 04:12 PM
Daniell Richard	Exec. VP, European Commercial	Mar 04 '25	Sale	15.56	12,936	201,253	0	Mar 05 04:12 PM
Hughes Eric A	See "Remarks"	Mar 03 '25	Sale	16.19	19,726	319,275	5,174	Mar 05 04:08 PM
Hughes Eric A	See "Remarks"	Mar 04 '25	Sale	15.56	5,174	80,495	0	Mar 05 04:08 PM
Francis Richard D	President and CEO	Mar 03 '25	Sale	16.19	24,892	402,889	251,783	Mar 05 04:04 PM
Francis Richard D	President and CEO	Mar 04 '25	Sale	15.56	6,450	100,347	245,333	Mar 05 04:04 PM
Fox Christine	Officer	Mar 04 '25	Proposed Sale	16.00	6,181	98,896		Mar 04 07:02 PM
McAvoy David R.	Officer	Mar 04 '25	Proposed Sale	16.00	4,827	77,232		Mar 04 06:57 PM
Hughes Eric A	Officer	Mar 04 '25	Proposed Sale	16.00	23,251	372,016		Mar 04 06:44 PM
Daniell Richard	Officer	Mar 04 '25	Proposed Sale	16.00	86,400	1,382,400		Mar 04 06:37 PM
Francis Richard D	Officer	Mar 04 '25	Proposed Sale	16.00	23,773	380,368		Mar 04 06:30 PM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Feb 28 '25	Sale	16.21	55,750	903,462	147,941	Mar 04 04:02 PM
Francis Richard D	Officer	Mar 03 '25	Proposed Sale	16.46	31,342	515,889		Mar 03 01:14 PM
Hughes Eric A	Officer	Mar 03 '25	Proposed Sale	16.46	24,900	409,854		Mar 03 01:07 PM
Daniell Richard	Officer	Mar 03 '25	Proposed Sale	16.46	62,250	1,024,635		Mar 03 12:59 PM
Kalif Eliyahu Sharon	Officer	Feb 28 '25	Proposed Sale	16.21	55,750	903,463		Feb 28 11:52 AM
Francis Richard D	President and CEO	Feb 18 '25	Sale	16.95	75,506	1,279,661	209,444	Feb 19 04:03 PM
Francis Richard D	Officer	Feb 18 '25	Proposed Sale	16.95	75,506	1,279,661		Feb 18 12:38 PM

KGC

Kinross Gold Corp

TEVA

Teva- Pharmaceutical Industries Ltd. ADR

Upgrade your FINVIZ experience